Archives: Drug Cards

Bupropion Bupropion is an atypical antidepressant and smoking‑cessation aid that functions primarily as a norepinephrine‑dopamine reuptake inhibitor (NDRI). It is distinct from serotonin‑modulating agents, making it a useful alternative for…

Buprenorphine Buprenorphine is a semi‑synthetic, high‑affinity partial agonist at the μ‑opioid receptor (MOR) used for both acute and chronic pain management as well as opioid use disorder (OUD) treatment. Its…

Buprenex Buprenex (generic buprenorphine) is a semi‑synthetic opioid often used for chronic pain management and opioid dependence treatment. It is a partial agonist at the μ‑opioid receptor with antagonistic activity…

Bupivacaine Bupivacaine is a long‑acting amide‑type local anaesthetic widely used for peripheral, epidural, and spinal anaesthesia. It offers profound analgesia with a relatively low risk of systemic toxicity when used…

Bunavail Bunavail is a fixed-dose combination of buprenorphine (a partial μ‑opioid receptor agonist) and naloxone (an opioid antagonist). Indicated for the treatment of opioid dependence and for the management of…

Bumex Bumex is the brand name for bumetanide, a potent loop diuretic used in the management of fluid overload. --- Mechanism of Action Inhibits the Na⁺‑K⁺‑2Cl⁻ cotransporter (NKCC2) in the…

Bumetanide Bumetanide is a potent loop diuretic used for volume overload and edema in various clinical settings. It acts on the Na⁺‑K⁺‑2Cl⁻ symporter in the thick ascending limb of the…

Budesonide Budesonide is a potent, lipophilic inhaled corticosteroid used for the treatment and prevention of airway inflammation in asthma and COPD, as well as for mucosal inflammation in gastrointestinal disorders…

I’m not aware of any medication named Bryhali in the current scientific or clinical literature. Because the drug is not recognized, I can’t provide reliable pharmacologic details. If you’re looking…

Brukinsa Brukinsa (ibrutinib) is an orally administered, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor indicated for several B‑cell malignancies. Mechanism of Action Irreversible covalent inhibition of BTK at Cys‑481, blocking B‑cell…